Blog

RSS Feed
Posted by Michael Wonder on 05 Aug 2015

Schedule of Pharmaceutical Benefits - 1 March 2015 update

The March 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The Schedule includes the following ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

ABPI statement in response to the 'Pharmaceutical Price Regulation Scheme Twelfth Report to Parliament'

[:content [\3 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \C \o \m \m \e \n \t \i \n \g \space \o \n \space \t \h \e \space \â \€ \˜ \P \h \a \r \m \a \c \e \u \t \i \c \a \l \space \P \r \i \c \e \space \R \e \g \u \l \a \t \i \o \n \space \S \c \h \e \m \e \space \T \w \e \l \f \t \h \space \R \e \p \o \r \t \space \t \o \space \P \a \r \l \i \a \m \e \n \t \â \€ \™ \, \space \A \B \P \I \space \C \h \i \e \f \space \E \x \e \c \u \t \i \v \e \space \S \t \e \p \h \e \n \space \W \h \i \t \e \h \e \a \d \space \s \a \i \d \: \  \\ \" \T \h \i \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015

Update for patient groups

Learn about CADTH's improvement to its patient input online submission system for the CADTH Common Drug Review, travel awards to the CADTH Symposium, ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

Approval of Novartis multiproduct proposal

PHARMAC is pleased to announce the approval of an agreement with Novartis New Zealand Ltd involving the listing of nine ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

New Zealand access to medicine worst in OECD

Kiwis have slower and less access to the newest and most innovative medicines than their OECD counterparts, according to a ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

Public Summary Documents from the March 2014 PBAC meeting (rejections)

The Public Summary Documents for the initial rejections and deferrals from the March 2014 PBAC meeting have been added to ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

NICE joins the SMC in recommending the use of Lucentis (ranibizumab) for macular oedema due to retinal vein occlusion

[:content [\N \I \C \E \space \r \e \c \o \m \m \e \n \d \s \space \t \h \e \space \u \s \e \space \o \f \  \r \a \n \i \b \i \z \u \m \a \b \space \a \s \space \a \space \p \o \s \s \i \b \l \e \space \t \r \e \a \t \m \e \n \t \space \f \o \r \space \s \o \m \e \space \p \e \o \p \l \e \space \w \h \o \space \h \a \v \e \space \s \i \g \h \t \space \p \r \o \b \l \e \m \s \space \b \e \c \a \u \s \e \space \o \f \space \m \a \c \u \l \a \r \space \o \e \d \e \m \a " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015

Ruxolitinib for myelofibrosis: indication of considerable added benefit

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis. In an early ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

Outcomes from the March 2014 PBAC meeting

[:content [\A \l \l \space \o \f \space \t \h \e \space \o \u \t \c \o \m \e \s \space \f \r \o \m \space \t \h \e \space \M \a \r \c \h \space \2 \0 \1 \4 \space \P \B \A \C \space \m \e \e \t \i \n \g \space \h \a \v \e \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \. \space \F \o \r \space \a \space \s \u \m \m \a \r \y \space \o \f " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015

Summary of outcomes from the March 2013 PBAC meeting

Submissions ...
Read more →
Posted by Michael Wonder on 05 Aug 2015

Public advises NICE on value of care

A group representing members of the general public in the UK has published its first draft report on what societal ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

German insurers win discounts on Gilead's Sovaldi

U.S. biotechnology company Gilead has conceded its first discounts in Germany on its key hepatitis C drugs Sovaldi and Harvoni, German business weekly WirtschaftsWoche ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

MAESTrO Australia PBAC - Links to MSAC assessments

27 February 2015 - The links to all MSAC assessments have been repaired. Thank you for your patience. ...

Read more →
Posted by Michael Wonder on 05 Aug 2015

Making medicines cheaper for consumers

[:content [\1 \7 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \T \h \e \space \M \i \n \i \s \t \e \r \space \f \o \r \space \H \e \a \l \t \h \, \space \P \e \t \e \r \space \D \u \t \t \o \n \, \space \t \o \d \a \y \space \a \n \n \o \u \n \c \e \d \space \n \e \w \space \l \i \s \t \i \n \g \s \space \o \n \space \t \h \e \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \space \B \e \n \e \f \i \t \s \space \S \c \h \e \m \e \space \( \P \B \S \) \space \f \o \r " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015

Dispensing Frequency amendment approved

PHARMAC is pleased to announce the approval of a proposal to amend the Pharmaceutical Schedule rules relating to the Dispensing ...

Read more →